Stocksigma LogoStocksigma Logo

NCLT Approves Docon-API Holdings Amalgamation; Thyrocare Promoter Holding Unchanged

The National Company Law Tribunal (NCLT) on 31st Aug'26 sanctioned the amalgamation of Docon Technologies with its parent, API Holdings

NCLT Approves Docon-API Holdings Amalgamation; Thyrocare Promoter Holding Unchanged

Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 10:51 pm

NCLT Approves Docon-API Holdings Amalgamation; Thyrocare Promoter Holding Unchanged The National Company Law Tribunal (NCLT) on 31st Aug'26 sanctioned the amalgamation of Docon Technologies with its parent, API Holdings. Consequently, Docon's entire 51.02% stake (81.2M shares) in Thyrocare will be transferred to API Holdings. This internal restructuring within the promoter group results in no change to the aggregate promoter shareholding of 51.02% in Thyrocare. The transaction consolidates the holding under API Holdings, while public shareholding remains unaffected at 48.98%.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements